Andexanet Alfa Versus 4-Factor PCC for Reversal of Intracranial Hemorrhage Associated With Factor Xa

Authors

Gregory Semon, Wright State UniversityFollow
Angela Straughn
Claire Hardman
Barbara Steel, Wright State UniversityFollow
Akpofure Peter Ekeh, Wright State UniversityFollow

Document Type

Conference Proceeding

Publication Date

1-2021

Repository Citation

Semon, G., Straughn, A., Hardman, C., Steel, B., & Ekeh, A. P. (2021). Andexanet Alfa Versus 4-Factor PCC for Reversal of Intracranial Hemorrhage Associated With Factor Xa. Critical Care Medicine, 49 (1), 615, 301.
https://corescholar.libraries.wright.edu/surg/802

DOI

10.1097/01.ccm.0000728348.25608.90